Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Should tocilizumab be the first line treatment for neuromyelitis optica together...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Should tocilizumab be the first line treatment for neuromyelitis optica together with rituximab?
¿Debería ser el tocilizumab el tratamiento de primera línea para la neuromielitis óptica junto con el rituximab?
R. Sawaya
Corresponding author
rs01@aub.edu.lb

Corresponding author.
, G. Saab, H. Moussa
Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon
Read
1009
Times
was read the article
249
Total PDF
760
Total HTML
Share statistics
Article information
ISSN: 21735808
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 12 3 15
2024 March 32 0 32
2024 February 17 3 20
2024 January 7 3 10
2023 December 33 14 47
2023 November 37 10 47
2023 October 29 11 40
2023 September 30 1 31
2023 August 24 5 29
2023 July 30 3 33
2023 June 45 2 47
2023 May 55 11 66
2023 April 27 7 34
2023 March 27 4 31
2023 February 14 10 24
2023 January 16 16 32
2022 December 20 14 34
2022 November 38 13 51
2022 October 20 5 25
2022 September 12 6 18
2022 August 22 6 28
2022 July 12 12 24
2022 June 26 4 30
2022 May 21 5 26
2022 April 11 5 16
2022 March 20 10 30
2022 February 23 8 31
2022 January 31 9 40
2021 December 40 14 54
2021 November 13 24 37
2021 October 16 11 27
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos